Pharmaceutical manufacturers / marketing authorisation holders have discontinued the sale of xx medicinal products that went through the benefit assessment procedure, affecting xx resolutions.
Log in to read more ...
The AMNOG monitor is a subscription-based service for pharmaceutical manufacturers and institutions. Enter your account details here in order to analyse the results of the early benefit assessment in Germany – or contact us for more information.
